- Home
- MOMO vs PHVS Comparison
MOMO vs PHVS Comparison
Compare MOMO & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOMO
- PHVS
- Stock Information
- Founded
- MOMO 2011
- PHVS 2015
- Country
- MOMO China
- PHVS Switzerland
- Employees
- MOMO N/A
- PHVS 119
- Industry
- MOMO Computer Software: Prepackaged Software
- PHVS Biotechnology: Pharmaceutical Preparations
- Sector
- MOMO Technology
- PHVS Health Care
- Exchange
- MOMO Nasdaq
- PHVS Nasdaq
- Market Cap
- MOMO 909.4M
- PHVS 1.4B
- IPO Year
- MOMO 2014
- PHVS 2021
- Fundamental
- Price
- MOMO $8.05
- PHVS $20.12
- Analyst Decision
- MOMO Buy
- PHVS Buy
- Analyst Count
- MOMO 2
- PHVS 6
- Target Price
- MOMO $10.00
- PHVS $37.17
- AVG Volume (30 Days)
- MOMO 919.2K
- PHVS 215.4K
- Earning Date
- MOMO 09-02-2025
- PHVS 08-13-2025
- Dividend Yield
- MOMO 3.73%
- PHVS N/A
- EPS Growth
- MOMO N/A
- PHVS N/A
- EPS
- MOMO 1.06
- PHVS N/A
- Revenue
- MOMO $1,450,201,337.00
- PHVS N/A
- Revenue This Year
- MOMO $1.04
- PHVS N/A
- Revenue Next Year
- MOMO $3.62
- PHVS N/A
- P/E Ratio
- MOMO $7.68
- PHVS N/A
- Revenue Growth
- MOMO N/A
- PHVS N/A
- 52 Week Low
- MOMO $5.12
- PHVS $11.51
- 52 Week High
- MOMO $9.22
- PHVS $26.33
- Technical
- Relative Strength Index (RSI)
- MOMO 42.16
- PHVS 48.68
- Support Level
- MOMO $7.94
- PHVS $19.12
- Resistance Level
- MOMO $8.25
- PHVS $22.30
- Average True Range (ATR)
- MOMO 0.18
- PHVS 1.22
- MACD
- MOMO -0.09
- PHVS -0.23
- Stochastic Oscillator
- MOMO 9.40
- PHVS 22.17
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.